TgVax452, an epitope-based candidate vaccine targeting Toxoplasma gondii tachyzoite-specific SAG1-related sequence (SRS) proteins: immunoinformatics, structural simulations and experimental evidence-based approaches
Our findings suggest that TgVax452 is a promising candidate vaccine against T. gondii tachyzoite-specific SRS proteins and requires further experimental studies for its potential use in preclinical trials.
Authors
- Hamidreza Majidiani (ORCID: https://orcid.org/0000-0001-5568-1366)
- Bahareh Kordi (ORCID: https://orcid.org/0000-0002-9272-6137)
- Mohammad M. Pourseif (ORCID: https://orcid.org/0000-0001-8314-2853)
- Mohammadreza Taban Sadeghi (ORCID: https://orcid.org/0000-0001-9577-0099)
- Alireza Najafi (ORCID: https://orcid.org/0000-0001-7781-3112)
Institutions
- Khazar University (AZ)
- University of Neyshabur (IR)
- Tabriz University of Medical Sciences (IR)
- University of Tabriz (IR)
- Technical and Vocational University (IR)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1186/s12879-024-09807-x
- Citations
- 18
- Primary Topic
- vaccines and immunoinformatics approaches
- Type
- article
- Field-Weighted Citation Impact
- 4.21